The potential benefit of 5% Sulfamylon Solution in the treatment of Acinetobacter baumannii-contaminated traumatic war wounds
- PMID: 16921408
- PMCID: PMC1501113
The potential benefit of 5% Sulfamylon Solution in the treatment of Acinetobacter baumannii-contaminated traumatic war wounds
Abstract
Background: The recent report of high numbers of Acinetobacter baumannii bloodstream infections among service members injured in Iraq and Afghanistan during the period January 2002 through August 2004 has prompted an investigation into their etiology. A review of the current guidelines for open combat casualty wounds as part of this broad investigation was not mentioned in the report.
Objective: The objective of this study was 2-fold: to ascertain the susceptibility of A. baumannii to currently available topical antibacterial agents and (2) to propose an alternative, effective treatment protocol for contaminated combat-related wounds so as to reduce or eliminate the likelihood of the wound serving as the source of A. baumannii infection or septicemia.
Methods: A standardized antimicrobial susceptibility study of 43 strains of A. baumannii collected from a tertiary care burn center was conducted using 2 commonly used topical antibacterial agents, 1% silver sulfadiazine cream (Silvadene) and 5% mafenide acetate solution (5% Sulfamylon Solution).
Results: Both were effective, but 5% Sulfamylon Solution demonstrated significantly greater antibacterial activity.
Conclusion: Five percent Sulfamylon Solution, initially developed for wartime use, and currently limited by the Food and Drug Administration to soaks following meshed split-thickness autografts following excision of second-degree and third-degree burns, has a broad spectrum of antibacterial activity and extensive off-label applicability. It is an ideal agent for use in the treatment of war wounds, and should be considered as a superior replacement for normal saline in the current guidelines for open combat casualty wounds.
Figures




Similar articles
-
The "Sulfamylon sandwich"--a laminated mafenide-saline dressing.Ann Plast Surg. 1980 Aug;5(2):157-9. doi: 10.1097/00000637-198008000-00015. Ann Plast Surg. 1980. PMID: 7004316
-
Use of 5% sulfamylon (mafenide) solution after excision and grafting of burns.J Burn Care Rehabil. 1988 Nov-Dec;9(6):602-5. doi: 10.1097/00004630-198811000-00005. J Burn Care Rehabil. 1988. PMID: 3065338
-
The antifibrinolytic activity of sulfamylon solution.Plast Reconstr Surg. 1988 Aug;82(2):281-4. doi: 10.1097/00006534-198808000-00012. Plast Reconstr Surg. 1988. PMID: 3041428
-
Topical mafenide hydrochloride aqueous spray in initial management of massive contaminated wounds with devitalized tissue.Prehosp Disaster Med. 2001 Jul-Sep;16(3):172-4. doi: 10.1017/s1049023x00025930. Prehosp Disaster Med. 2001. PMID: 11875802 Review.
-
Topical treatment for facial burns.Cochrane Database Syst Rev. 2020 Jul 29;7(7):CD008058. doi: 10.1002/14651858.CD008058.pub3. Cochrane Database Syst Rev. 2020. PMID: 32725896 Free PMC article.
Cited by
-
Burn Wound Healing and Tissue Engineering.J Burn Care Res. 2017 May/Jun;38(3):e605-e613. doi: 10.1097/BCR.0000000000000538. J Burn Care Res. 2017. PMID: 28328668 Free PMC article. Review.
-
A simple cost-saving measure: 2.5% mafenide acetate solution.J Burn Care Res. 2014 Jul-Aug;35(4):349-53. doi: 10.1097/BCR.0b013e3182a22715. J Burn Care Res. 2014. PMID: 24043238 Free PMC article.
References
-
- Centers for Disease Control and Prevention Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002–2003. MMWR Morb Mortal Wkly Rep. 2004;53(45):1063–1066. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5345a1.htm. - PubMed
-
- Blankenship CL. Guidelines for care of open combat casualty wounds. [Accessed January 2005]. Available at: http://www.geis.fhp. osd.mil.
-
- Robson MC. Infection in the surgical patient: an imbalance in the wound equilibrium. Clin Plast Surg. 1979;6:493–503. - PubMed
-
- Robson MC, Edstrom LE, Krizek TJ, Groskin MG. The efficacy of systemic antibiotics in the treatment of granulating wounds. J Surg Res. 1974;16:229–306. - PubMed
-
- Edlich RF, Smith QT, Edgerton MT. Resistance of the surgical wound to antimicrobial prophylaxis and its mechanisms of development. Am J Surg. 1973;126:583–593. - PubMed
LinkOut - more resources
Full Text Sources